Discrepancies between commercially available immunoassays in the detection of tumour-derived hCG.
Mitchell
Hugh
H
Gestational Trophoblastic Disease Unit, Department of Medical Oncology, Charing Cross Hospital Campus of Hammersmith Hospitals NHS Trust, London W6 8RF, UK. h.mitchell@imperial.ac.uk
Seckl
Michael J
MJ
D000951:Antigens, Neoplasm / Q000032:analysis*; D006063:Chorionic Gonadotropin / Q000032:analysis*; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D011863:Radioimmunoassay / Q000379:methods* / Q000592:standards; D011933:Reagent Kits, Diagnostic / Q000592:standards
D000951:Antigens, Neoplasm; D006063:Chorionic Gonadotropin; D011933:Reagent Kits, Diagnostic